Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment: Insights From VOYAGER PAD

Circulation. 2024 Feb 20;149(8):635-637. doi: 10.1161/CIRCULATIONAHA.123.065330. Epub 2024 Feb 20.
No abstract available

Keywords: chronic limb-threatening ischemia; endovascular procedures; ischemia; peripheral arterial disease; rivaroxaban; vascular surgical procedures.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chronic Limb-Threatening Ischemia* / drug therapy
  • Chronic Limb-Threatening Ischemia* / etiology
  • Chronic Limb-Threatening Ischemia* / surgery
  • Endovascular Procedures* / adverse effects
  • Humans
  • Ischemia / diagnostic imaging
  • Ischemia / drug therapy
  • Ischemia / surgery
  • Limb Salvage
  • Lower Extremity / blood supply
  • Peripheral Arterial Disease / diagnostic imaging
  • Peripheral Arterial Disease / drug therapy
  • Peripheral Arterial Disease / surgery
  • Randomized Controlled Trials as Topic
  • Risk Factors
  • Rivaroxaban* / therapeutic use
  • Treatment Outcome
  • Vascular Surgical Procedures*

Substances

  • Rivaroxaban

Associated data

  • ClinicalTrials.gov/NCT02504216